pteridines has been researched along with Invasiveness, Neoplasm in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Effects of TG100-115 on breast cancer cell proliferation, migration, invasion, myosin IIA phosphorylation, and TRPM7 ion channel activity were assessed by using MTT, wound healing, transwell assay, Western blotting, and patch clamping, respectively." | 7.85 | Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion. ( Bae, Y; Hur, W; Jun, J; Kim, ND; Lee, H; Lee, KB; Park, JY; Sim, T; Song, C, 2017) |
| "Transforming growth factor beta (TGFbeta) is a pleiotropic factor that regulates cell proliferation, angiogenesis, metastasis, and immune suppression." | 5.34 | Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness. ( Chakravarty, S; Damm, DL; Gaspar, NJ; Henson, M; Higgins, LS; Kapoun, AM; Li, G; Li, L; Medicherla, S; Muiru, GT; Murphy, A; O'Young, G; Quon, D; Reddy, M; Wong, DH, 2007) |
| " Effects of TG100-115 on breast cancer cell proliferation, migration, invasion, myosin IIA phosphorylation, and TRPM7 ion channel activity were assessed by using MTT, wound healing, transwell assay, Western blotting, and patch clamping, respectively." | 3.85 | Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion. ( Bae, Y; Hur, W; Jun, J; Kim, ND; Lee, H; Lee, KB; Park, JY; Sim, T; Song, C, 2017) |
| "Transforming growth factor beta (TGFbeta) is a pleiotropic factor that regulates cell proliferation, angiogenesis, metastasis, and immune suppression." | 1.34 | Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness. ( Chakravarty, S; Damm, DL; Gaspar, NJ; Henson, M; Higgins, LS; Kapoun, AM; Li, G; Li, L; Medicherla, S; Muiru, GT; Murphy, A; O'Young, G; Quon, D; Reddy, M; Wong, DH, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulrahman, N | 1 |
| Siveen, KS | 1 |
| Joseph, JM | 1 |
| Osman, A | 1 |
| Yalcin, HC | 1 |
| Hasan, A | 1 |
| Uddin, S | 1 |
| Mraiche, F | 1 |
| Fan, L | 1 |
| Li, P | 1 |
| Yin, Z | 1 |
| Fu, G | 1 |
| Liao, DJ | 1 |
| Liu, Y | 1 |
| Zhu, J | 1 |
| Zhang, Y | 1 |
| Wang, L | 1 |
| Yan, Q | 1 |
| Guo, Y | 1 |
| Shao, C | 1 |
| Huang, G | 1 |
| Wang, Z | 1 |
| Song, C | 1 |
| Bae, Y | 1 |
| Jun, J | 1 |
| Lee, H | 1 |
| Kim, ND | 1 |
| Lee, KB | 1 |
| Hur, W | 1 |
| Park, JY | 1 |
| Sim, T | 1 |
| Mohammad, KS | 1 |
| Javelaud, D | 1 |
| Fournier, PG | 1 |
| Niewolna, M | 1 |
| McKenna, CR | 1 |
| Peng, XH | 1 |
| Duong, V | 1 |
| Dunn, LK | 1 |
| Mauviel, A | 1 |
| Guise, TA | 1 |
| Ding, Y | 1 |
| Huang, D | 1 |
| Zhang, Z | 1 |
| Smith, J | 1 |
| Petillo, D | 1 |
| Looyenga, BD | 1 |
| Feenstra, K | 1 |
| Mackeigan, JP | 1 |
| Furge, KA | 1 |
| Teh, BT | 1 |
| Gaspar, NJ | 1 |
| Li, L | 1 |
| Kapoun, AM | 1 |
| Medicherla, S | 1 |
| Reddy, M | 1 |
| Li, G | 1 |
| O'Young, G | 1 |
| Quon, D | 1 |
| Henson, M | 1 |
| Damm, DL | 1 |
| Muiru, GT | 1 |
| Murphy, A | 1 |
| Higgins, LS | 1 |
| Chakravarty, S | 1 |
| Wong, DH | 1 |
6 other studies available for pteridines and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells.
Topics: A549 Cells; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autop | 2020 |
Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Butadienes; Carcinoma, Renal Cell; Cell Cycle; Cell Line | 2013 |
Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion.
Topics: Adenosine Triphosphate; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cycli | 2017 |
TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases.
Topics: Animals; Base Sequence; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Disease Progressio | 2011 |
Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Cycle Proteins; Cell Line, Tumor; Female | 2011 |
Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Topics: Activin Receptors, Type I; Adenocarcinoma; Animals; Cell Line, Tumor; Cell Proliferation; Genes, myc | 2007 |